CENPA is a centromere-associated variant of histone H3 implicated in numerous malignancies. However, the role of this protein in glioblastoma (GBM) has not been demonstrated. GBM is one of the most aggressive human cancers. GBM initiating cells (GICs), contained within these tumors are deemed to convey characteristics such as invasiveness and resistance to therapy. Therefore, there is a strong rationale for targeting these cells. We investigated the expression of CENPA and other centromeric proteins (CENPs) in GICs, GBM and variety of other cell types and tissues. Bioinformatics analysis identified the gene signature: high_CENP(AEFNM)/low_CENP(BCTQ) whose expression correlated with significantly worse GBM patient survival. Knockdown of CENPA reduced sphere forming ability, proliferation and cell viability of GICs. We also detected significant reduction in the expression of stemness marker SOX2 and the proliferation marker Ki67. These results indicate that CENPA might represent a promising therapeutic target for GBM treatment.
Introduction
Glioblastoma (GBM) is one of the most malignant human cancers with dismal prognosis. Despite multimodal therapy and inclusion of temozolomide, median survival remains unchanged (Helseth et al., 2010; Ronning et al., 2012) . Glioblastoma initiating cells (GICs), a cell population with stem cell properties (also referred to as glioblastoma stem cells, GSCs) harbored with within these tumors are deemed important for retaining GBM properties (Galli et al., 2004; Singh et al., 2003; Vescovi et al., 2006) . GICs are invasive (Cheng et al., 2011; Molina et al., 2010) , promote tumor angiogenesis (Folkins et al., 2009; Das and Marsden, 2013; Bao et al., 2006) and are resistant to irradiation and chemotherapy (Bao et al., 2006; Chen et al., 2012; Liu et al., 2006) . Consequently, there is a strong rationale for targeting these cells.
We have compared gene expression in GICs to that in neural stem cells (NSCs) from the adult human brain, and identified genes and biochemical pathways typically up-regulated in GICs Stangeland et al., 2015) . Although these two cell types share common stem-and lineage-related markers, GICs show a more heterogeneous gene expression and a number of pathways such as Wnt signaling, cell cycle and p53 signaling are dysregulated in GICs . This analysis also revealed a 30-gene signature highly up-regulated in GICs that had an impact on survival of glioma patients . Recently we identified a glioblastoma-specific coexpression module that consisted of PBK/TOPK, CENPA, KIF15, DEPDC1, CDC6, DLG7/DLGAP5/HURP, KIF18A, EZH2, HMMR/ RHAMM/CD168, NOL4, MPP6, MDM1, RAPGEF4, RHBDD1, FNDC3B, FILIP1L, MCC, ATXN7L4/ATXN7L1, P2RY5/LPAR6 and FAM118A . All nine genes in the module were highly up-regulated in GBM and were predominantly involved in cell division, cell-cycle and proliferation . The cumulative increased expression of this nine-gene module correlated negatively with survival of GBM patients thus suggesting that they might represent potential therapeutic targets . Two of the genes KIF15 and KIF18A were involved in mitotic kinesis . KIF15 is required for spindle function and has recently been targeted by using quinazolinedione and phthalimide (Mcdonald et al., 2004) . KIF18A is involved in chromosome congression and a specific inhibitor BTB1 that targets this gene was recently discovered (Catarinella et al., 2009 ). Knockdown of a further three genes: HMMR (Tilghman et al., 2014) , EZH2 (Suva et al., 2009) and PBK resulted in severe reduction of tumorigenic features of GICs.
One of the nine genes, encoding a centromeric protein 'A' (CENPA), was highly up-regulated in GICs both at RNA and protein levels . CENPA, is a variant of histone H3 (Sullivan et al., 1994 ) that was firstly identified in scleroderma patients (Moroi et al., 1980; Earnshaw and Rothfield, 1985) . CENPA homologs have been identified in organisms from yeast to human, where they serve as markers of centromeric chromatin identity (Verdaasdonk and Bloom, 2011) . During cell division the centromere recruits the kinetochore that additionally attaches to the spindle. CENPA secures proper kinetochore function (Howman, 2000; Blower and Karpen, 2001; Oegema et al., 2001) by recruiting the inner kinetochore proteins CENPC, CENPN and CENPB (Guse et al., 2011; Carroll et al., 2009; Ando et al., 2002) . The kinetochore interface consists of a large number of other centromere proteins (CENPs) that form constitutive a centromere-associated network (CCAN) (for overview see McKinley and Cheeseman and the references therein) (McKinley and Cheeseman, 2016) . CENPA is also involved in response to DNA damage and ensures genome integrity (Mathew et al., 2014; Lawrence et al., 2015) . Several recent reports implicate CENPA in numerous human cancers such as breast, liver, colon, lung, blood, ovarian and pancreatic (Zhang et al., 2014; Habel et al., 2013; Toh et al., 2011; Rajput et al., 2011; Hu et al., 2010; Biermann et al., 2007a; Biermann et al., 2007b; Furukawa et al., 2006; Li et al., 2007; Tomonaga et al., 2003; Qiu et al., 2013) . Increased expression of CENPA gene correlates negatively with patient survival (Zhang et al., 2014; Habel et al., 2013; Qiu et al., 2013) . CENPA is also associated with the transformation of lymphoblasts by Epstein-Barr virus (Dai et al., 2012) .
Although the significance of CENPA in human cancers has been documented its relevance in GBM and GICs remains to be demonstrated. In this paper we investigated the expression of CENPA and several other CENPs in GBM, brain tissues, GICs, NSCs, a neural fetal cells (NFCs) line, induced pluripotent stem cells (iPS), dopaminergic neurons and many other cell and tissue types using bioinformatics analysis. We also investigated the effect of CENPA gene knock-down on sphere forming ability, stemness and proliferation of GICs.
Materials and methods

Tissue specimens and cell culture
The study was approved by the Regional committee for medical and health research ethics (REC South-East S-07321d). Biological material and personal health data have been collected and used in accordance with informed consent from patients included in the study and in compliance with the institutional guidelines pertaining to use of such issued by the department of research support at Oslo University Hospital. Tissue specimens were harvested from consenting patients and were obtained as a part of surgical procedures for treating GBM. Normal brain tissue was obtained from fresh human temporal lobes surgically resected to treat medically refractory epilepsy. All biopsy specimens were evaluated by neuropathologists.
Tumor biopsies underwent mechanical dissociation and Trypsin-EDTA (Gibco, Life Technologies, NYC, NY, USA) was added for enzymatic dissociation. Subsequently, 2 mg/ml human albumin (Octapharma pharmazeutika produktionges, Vienna, Austria) was used to block the Trypsin effect and the cells were washed in L-15 (Lonza, Basel, Switzerland) before being plated in serum-free neurosphere medium containing 10 ng/ml basic fibroblast growth factor (bFGF) and 20 ng/ml epidermal growth factor (EGF) (both R&D Inc., Minneapolis, MN, USA), B27-supplement (1:50, Invitrogen, Carlsbad, CA, USA), 100 U/ml Penicillin/streptomycin (Lonza), 1 ng/ml Heparin (Leo Pharma, Ballerup, Denmark) and 8 mM Hepes (Lonza) in Dulbecco's modified essential medium with nutrient mix F-12 and Glutamax (DMEM/F12, Invitrogen). Dissociated GBM biopsies grown as freefloating spheres in serum free-medium containing mitogens (EGF and bFGF) are highly enriched for GICs. GIC culture T65 was previously extensively characterized for stemness (CD133, CD44, SSEA-1/CD15, CXCR4, CD9, CD166, A2B5) and tumor forming capability by transplanting into the brain of SCID mice Joel et al., 2015) . The cells were cultured in 75 cm 2 non-treated flasks (Nunc, Roskilde, Denmark) at a density of 10⁵ cells/ml and supplemented with EGF and bFGF twice a week. When the spheres reached approximately 100 μm in diameter they were dissociated into single cells. Tissue specimens from the adult human brain were dissociated into single cells and cultured according to our FAILSAFE protocol (1% FBS, 10 ng/ml bFGF and 20 ng/ml TGF α) that ensures robust long-term propagation of multipotent stem cells from the adult human brain .
Microarray analysis and public database mining
Hierarchical clustering with distance matrix and the Principal Component Analysis were performed using J-Express software (Molmine, Bergen, Norway). For these analyses we used our microarray expression data derived from GIC, neural fetal cells (NFCs), brain tissue and NSC cultures with submission numbers GSE60705, GSE53800, GSE41470 (encompassing GSE41467, GSE41390, and GSE41394), as well as the following publically available (GEO repository) microarrays encompassing: additional sets of GICs (GSE36426), astrocytes (GSE47515), breast cancer stem cells and cell lines (GSE34987, GSE36102), iPS (GSE43364, GSE43903, GSE41565), GBM cell lines (GSE43452), iPS derived partially differentiated neurons (GSE42265), NSCs (GSE32658), ESCs and fibroblasts (GSE37077) and leukocytes (GSE42133).
For Fig. 2 : The expression of eleven CENPs was analyzed in the previously defined subset of 200 GBM samples from TCGA (Verhaak et al., 2010) . PCA, HCA and HCA with distance matrix were performed using J-express, Molmine, Bergen, Norway.
Fig . 1D and Supplemental Fig. 2 : For PCA analysis we downloaded the following subsets from GEO superseries GSE27869: GSM688128 (CENPA KD), GSM688129 (CENPB KD), GSM688130 (CENPC1 KD), GSM688131 (CENPE KD), GSM688132 (CENPF KD), GSM688133 (CENPH KD). The above-mentioned microarrays were from GE Healthcare microarray platform GPL4044 (spotted oligonucleotide, CodeLink UniSet Human 20 K I Bioarray). Each culture featured only a single CENP gene knockdown as specified. Bioinformatic analysis was performed in J-Express.
For calculation of statistical parameters, we used Graphpad Prism (www.graphpad.com).
Western blot and quantification of protein expression
The cells were homogenized by triturating in Cell Extraction Buffer (Mammalian cell extraction kit, Biovision, Milpitas, CA, USA) and centrifuged through a QIAshredder (Qiagen, Venlo, Netherlands). 20-40 μg of whole protein extract were mixed with loading buffer (NuPAGE, Invitrogen) and loaded onto a 4-20% gradient Nu-PAGE gel (Invitrogen). Protein gels were blotted onto 0.45 μm PVDF membranes (Invitrogen) and western blots were performed as previously described . For western blot we used following primary antibodies: Anti-CENPA (#2186, rabbit, 1:1000), Anti-ACTIN-B (#4967, rabbit, 1:1000) both from Cell Signaling technologies (CST). The secondary antibody was ECL Anti-rabbit IgG-HRP (NA934, 1:10000, Amersham). Protein quantification was performed as previously described . Briefly, CENPA and ACTB (actin) protein bands from the same lane were quantified using densitometry function in Photoshop. ACTB was used as a control for normalization. The Relative Protein Expression (RPE) values were calculated by normalizing CENPA band intensities to those of ACTB. The RPE values for KDs were then normalized to non-silencing control and used for comparison.
RNAi-mediated gene knockdown
GIC culture T65 was used to establish stable CENPA knockdown cultures KD1 (Clone ID V3LHS_403419), KD2 (V2LHS_150535), KD3 (V3LHS_313522), KD4 (V3LHS_403420) and a non-silencing (NS) shRNA as a control (RHS4346) Scientific, Huntsville, AL, USA). Production of virus and transduction were performed as previously described . The cells were selected on 1-3 μg/ml Puromycin (Sigma-Aldrich, St. Louis, MO, USA).
Cell viability and sphere forming assay
For analysis of cell viability we used a colorimetric test based on tetrazolium salt -XTT (Roche Diagnostics, Indianapolis, IN, USA) according to instructions from the manufacturer and previously described procedure . P-values were calculated using non-parametric Mann-Whitney test.
The sphere forming assay was done by seeding single cell suspensions containing 500 cells per well in ultra-low attachment flat bottom 96-well plates for 10 days (Sarstedt). Subsequently, the plates were imaged using GelCount™ (Oxford Optronics, Abington, UK). Only spheres N 50 μm were taken into consideration and 10 wells were evaluated for each cell culture. The number and the size (average area) of spheres were measured using software supplied by the manufacturers. All results were presented as a mean of five to six independent experiments ± standard deviation. P-values were calculated using the non-parametric Mann-Whitney test. Sphere volume was calculated both by using the mathematical formula V = (4/3)πr 3 (shown in Fig. 7 and the Supplemental Fig. 4 ) and confirmed using the sphere volume function integrated in the Gelcount software (not shown).
Immunolabeling
GIC cultures were plated in 24-well plates (Sarstedt) or chamber slides (Sigma-Aldrich) pretreated with Retronectin 50 μg/ml (Takara) and incubated overnight to facilitate cell adhesion. Cells were fixed with 4% PFA and washed with PBS. Immunolabeling was performed as previously described .
For detection of CENPA protein we used the primary antibody Anti-CENPA [#2186, rabbit, 1:400, CST]. The secondary antibody was: Alexa Fluor 594 A11012 (goat anti-rabbit, 1:500, Invitrogen).
Flow cytometry
Spheres from GSC culture T65 were dissociated into single cells, and incubated overnight to recover. Cells were pelleted, and incubated with primary antibodies against CD133/2-PE conjugated (Miltenyi biotec) and SSEA1-PE conjugated (Becton-Dickinson). Cells were then analyzed using a LSRII flow cytometer (Becton-Dickinson). We used the following primary antibodies: Anti-Ki67 (ab16667, rabbit monoclonal, Abcam) and Anti-SOX2 (MAB2018, mouse monoclonal, RD Systems).
Results
Expression of CENPA and other CENPs in GBMs, GICs, NSCs and variety of human cell types
Expression of CENPA and the genes encoding other centromeric proteins was assessed in a range of cell types, using our microarrays and public data available in the GEO repository ( Fig. 1 and Supplemental Fig. 1 ). The expression of a variety of CENPs was analyzed using hierarchical cluster analysis (Fig. 1) . In addition to GICs, NSC, GBM, commercial GBM cell lines and brain tissues we also included the following: neural fetal cells (NFCs), astrocytes, iPS, embryonic stem cells (ESCs), fibroblasts, partially or fully differentiated dopaminergic neurons, primary breast cancer cells (BCC) and leucocytes ( Fig. 1A, Supplemental Fig. 1 ). Our hierarchical cluster analysis showed that genes encoding for CENPs are expressed in many cell types and tissues (Fig. 1A) . While the whole group of genes encoding for CENPs seems to be universally down-regulated in leucocytes the gene CENPC1 was up-regulated (Fig. 1A) . Using principal component analysis (PCA) we compared the expression profiles of genes encoding CENPs in the aforementioned set of cultures and tissues. This analysis revealed that the majority of CENPs exhibited similar profiles (Supplemental Fig. 1A -B) except for CENPV, CENPF and CENPB that seem to be outliers (Supplemental Fig. 1A-B) . Hierarchical cluster analysis further separated all samples into two categories (Fig. 1A) . The first category consisted of undifferentiated and partially differentiated cell types while the second category contained predominantly differentiated cells such as fully differentiated dopaminergic neurons and leukocytes (Fig. 1A) . The "undifferentiated" category consisted of GICs, BCCs, GBM tissues, GBM commercial cell lines, ESCs and NSCs. When only this category was analyzed the samples were separated roughly to NSCs and cancer stem/progenitor cell cultures (Fig. 1B) . The "partially differentiated and mixed" cell cultures group consisted of undifferentiated and partially differentiated iPS, fibroblasts, some GBM primary cell cultures and a series of incompletely differentiated dopaminergic neurons (Fig. 1A) .
By selecting the 17 most variable CENP-encoding genes in the GIC cultures and commercial GBM cell lines we separated these cultures into two clusters (Fig. 1C) . Cultures in the first and the second cluster were characterized by relatively lowly and relatively highly expressed CENPV respectively. Interestingly, GBM commercial lines were low in CENPV. While the majority of the selected genes encoding CENPs were typically highly expressed in the selected cultures there were several cultures where the CENP genes were lowly expressed (Fig. 1C , red dendrogram branches/lines on the left).
To further investigate the functional relationship between CENPA and other CENPs we downloaded gene expression data from the study where several hundreds of genes were knocked down ( Fig. 1D and Supplemental Fig. 2A-B) (Hurley et al., 2012) . This data set contained gene expression profiles of human umbilical vein endothelial cell (HUVEC) cultures featuring single knockdowns (KDs) of CENPA, CENPB, CENPC1, CENPE, CENPF and CENPH. Global analysis of gene expression revealed that knockdowns of CENPA and CENPF lead to similar gene expression profiles thus indicating a very close functional relationship between these two CENPs (Fig. 1D) . Furthermore, global gene expression profiles of cell cultures featuring knockdowns of CENPA, CENPF, CENPC1 and CENPB appeared to bear certain similarities to one other (Supplemental Fig. 2A ). Knockdowns of these four genes all down-regulated the same set of genes while the knockdown of CENPE and CENPH leads to the up-regulation of the same set (Supplemental Fig. 2B ). The set of genes, differentially regulated between the two groups, encompassed genes involved in regulation 
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of innate immunity, differentiation and mitochondrial function (Supplemental Fig. 2B ).
Expression of CENPs in clinical GBM samples from TCGA
The Cancer Genome Atlas (TCGA) database comprises of large amount of expressional data gathered from a vast number of cancer tissues (http://cancergenome.nih.gov). The TCGA GBM tissue set was previously described and divided into four putative GBM subtypes: proneural, neural, mesenchymal and classical according to the expression patterns of 840 identifier genes (Verhaak et al., 2010) . The GBM subtypes all carried distinct mutations and had a pronounced relevance in clinical settings. We analyzed the expression of CENPA in clinical GBM samples from the TCGA database. The expression of the CENPA gene was significantly higher in proneural tumors than in mesenchymal and classical tumors ( Fig. 2A) . Further, we analyzed the expression of all genes encoding CENPs that were present on the TCGA beadchip using PCA and cluster analysis. Global analysis of the expression data for 200 GBM tissue samples from TCGA (Verhaak et al., 2010) revealed similarities in expressions of CENPA, CENPM, CENPN, CENPQ, CENPC1 and CENPT (Fig. 2B-C) . PCA also revealed that PC1, PC2 and PC3 identified CENPF, CENPB and CENPE as outliers, respectively (Fig. 2B-C) . We further tested if the genes encoding CENPs were differentially regulated in GBM subtypes using PCA. This analysis showed that the CENP gene expression patterns clearly separated proneural and neural tumors from the mixture of classical, mesenchymal and few neural samples (Fig. 2D) . Curiously, the unclassified TCGA GBM tissue samples (black) were not evenly spread and congregated predominantly with the proneural or mesenchymal/ classical assemblies (Fig. 2D) .
To analyze the co-expression of CENP genes we performed hierarchical cluster analysis on the same set from TCGA (Verhaak et al., 2010) . This analysis revealed consistently high expression of CENPF in clinical samples (Fig. 2E) . CENPJ and CENPI were lowly expressed in GBM tissues and were therefore excluded from some analyses (Fig. 2E) . The expression values of CENPA clustered together with CENPN, CENPE, CENPF and CENPM (Fig. 2E) while CENPB, CENPI, CENPC1, CENPT, CENPQ and CENPJ clustered with one another (Fig. 2E) . The two gene clusters: CENP(AEFNM) and CENP(BCTQ) were confirmed using another clustering method (Fig. 2F) . We further tested if the expression of the two following gene signatures: a) CENP(AEFNM)_HIGH/CENP(BCTQ)_LOW and b) CENP(AEFNM_LOW/ CENP(BCTQ)_HIGH had an impact on patient survival. When all GBM tissue samples from the TCGA set (Verhaak et al., 2010) were tested there was no significant effect on patient survival (Supplemental Fig. 3A-B) . However, when only the mesenchymal tissue samples were analyzed (Fig.  2G) the expression of the signature CENP(AEFNM)_HIGH/CEN-P(BCTQ)_LOW correlated with significantly worse survival (Fig. 2H) .
Expression of CENPA protein in GICs
We have previously shown that CENPA was up-regulated in GIC cultures and GBM tissues at mRNA and protein levels . Here we evaluated the expression of CENPA in GICs using immunolabeling with a CENPA specific antibody (Fig. 3) . CENPA protein was detected in the nuclei of GICs represented by a very specific spotty pattern (Fig. 3B) . The intensity of the signal was varying from nucleus to nucleus and some nuclei distinguished themselves by both very bright spotty CENPA staining and a "cloudy" appearance in the surrounding nucleoplasm (Fig. 3E ). This additional staining could indicate ectopic assemblage of CENPA protein in the peri-centromeric regions or along the chromosomes (neocentromeres). CENPA was otherwise expressed exclusively in the nuclei where it overlapped (Fig. 3C and F) with DAPI staining (Fig. 3A and D) .
Expression of CENPA in GICs during mitosis was followed using immunolabeling (Figs. 3-4) . During interphase the expression of CENPA in GICs was nuclear and appeared typically either as spotty patterns (Fig. 3B) or "spotty + cloudy" patterns (Fig. 3E) . During prophase the spotty pattern disappeared and was replaced by a diffuse appearance (Fig. 3H) . During the other phases of mitosis the typical patterns disappeared and the CENPA protein could also be detected in the cytoplasm (Fig. 4B, E, H and K) . The characteristic mitotic figures were documented using DAPI staining (Fig. 4A , D, G and J).
CENPA gene knockdown in GIC cultures
To investigate the function of CENPA in GICs we performed knockdown of this gene using RNAi technology. We utilized four different shRNA constructs and a non-silencing (NS) control. To assess the efficiency of CENPA gene knockdown we used qPCR (not shown), western blot ( Fig. 5A-B) and immunolabeling (Fig.  6) . Quantification of western blots showed that the levels of CENPA were reduced by 20-70% in the knockdown cultures KD1, KD2, KD3 and KD4 (Fig. 5A-C) . The relative expression of CENPA protein in knockdown cultures was also investigated using immunolabeling. This analysis showed that the levels of CENPA were reduced in nuclei of knockdown cultures (Fig. 6 ). In conclusion, the immunolabeling showed significant reduction in CENPA protein levels in all four KD cultures (not shown for KD2). The intensity of CENPA-specific signal was lowest in KD3 and KD4 ( Fig. 6J and N) . The GFP expression is presented in green (Fig. 6C , G, K and O).
Knockdown of CENPA reduces stemness and sphere forming ability of GICs
Knockdown of CENPA gene resulted in impaired growth of GIC cultures grown as spheres (Figs. 5 and 7) . GBM spheres featuring CENPA KD were smaller in size ( Fig. 5D and Supplemental Fig. 4A ). To test the expression of markers for stemness and cell proliferation we performed flow cytometry analysis. This analysis revealed reduced levels of the cell proliferation marker Ki67 and the stemness marker SOX2 in KD2, KD3, and KD4 cultures but not in the less efficient KD1 culture (Fig. 5E) . To investigate the degree of linear dependence between the protein levels of CENPA and SOX2 and CENPA and Ki67 we compared the quantified western data to the FACS data using Fig. 2 . Expression of CENP genes in glioblastoma tissue samples from TCGA. A. TCGA divided all GBM clinical samples into four subtypes: proneural, classical, neural and mesenchymal (Verhaak et al., 2010) . CENPA is significantly up-regulated in the proneural GBM subtype. Asterisks correspond to p values and indicate levels of significance. "**" here corresponds to p = 0.0043 while "***" corresponds to p = 0.002. P values were calculated using a Mann-Whitney non-parametric test. B. The expression of eleven CENPs in GBM samples from GBM TCGA. 2D plot of principal component analysis (PCA) showing separation of CENP genes according to their expression in GBM tissues from TCGA. PCA showed grouping of CENPs (CENPF, CENPB and CENPE were outliers). The higher proximity of CENP genes in PCA indicates a higher level of co-expression in GBM samples. C. 3D plot of the PCA analysis in B. D. PCA analysis of CENPs expression in subtypes of GBM from TCGA (same set as in A). This analysis showed that CENPs are not randomly expressed in GBM subtypes. The proneural (dark blue) and neural (light blue) subtypes could be separated from the rest of GBMs according to CENP expression. E. Hierarchical cluster analysis of CENP genes in GBMs from TCGA (Verhaak et al., 2010) Pearson product-moment correlation coefficient (PPMCCr) calculation. Correlation was excellent: r = 0.91 and r = 0.96 for CENPA/ SOX2 and CENPA/Ki67 levels respectively.
To assess cell growth of cell cultures featuring CENPA knockdown we measured cell viability using XTT kit. Moderate but significant reduction in cell viability was observed in all cultures (Fig. 7A) . In the KD1 cell culture cell viability was assessed in subsequent passages up to 80 days after transduction (Supplemental Fig. 4B ). This culture started showing reduced cell viability only gradually and after 72 days in culture it was half as high as in the NS control (Supplemental Fig.  4B ).
Sphere forming ability is usually considered as a retrospective assay to estimate the number of tumor initiating cells. Spheres featuring CENPA knockdown appeared smaller than the corresponding "wild-type" spheres (Fig. 5D) . To quantify the effect of CENPA KD on sphere forming ability we performed a sphere forming assay (SFA) (Fig. 7B-D and Supplemental Fig. 4C-D) . SFA assays performed in all four cultures showed reduced sphere forming abilities. While the average diameter of spheres in NS was 94.93 ± 12.16 μm, the diameter of spheres featuring CENPA knockdown was reduced to 81.26 ± 9.08 μm, 74.80 ± 10.18 μm, 80.88 ± 13.75 μm and 86.50 ± 18.63 μm in KD1, KD2, KD3 and KD4 respectively (Fig. 7B) . The average number of spheres in NS was 47.13 ± 8.72 (Fig. 7C ). This number was significantly reduced in the knockdown cultures: KD1 (27.97 ± 48.73), KD2 (26.80 ± 11.78), KD3 (25.07 ± 7.34) and KD4 (28 ± 12.05) (Fig. 7C) . The total sphere volume per well (TSVPW) was dramatically reduced in all tested knockdown cultures (Fig. 7D) 7D ).
In one culture (KD1) we assessed the effect of CENPA KD on sphere forming ability also on days 42 (Supplemental Fig. 4C ), 56 (not shown) and 73 (Supplemental Fig. 4D ) after transduction (as outlined in Supplemental Fig. 4B ). The parameters of the SFA in KD1 were significantly reduced after 42 days in this culture and the difference became even more prominent after 72 days (Supplemental Fig. 4C-D) . Other cultures (KD2, KD3 and KD4) showed only small fluctuations after prolonged incubation.
To calculate the degree of linear dependence between the knockdown efficiencies and the results of the functional assays we used again the Pearson product-moment correlation coefficient (PPMCCr) calculation. Correlations between the average number of spheres and knockdown efficiency and the sphere diameter (median) and knockdown efficiency were r = 0.67 and r = 0.81 respectively. Correlations between the average cell viability and knockdown efficiency and the average volume of spheres (per well) and knockdown efficiency were r = 0.43 and r = 0.56 respectively. In conclusion, while the size and number of the spheres correlated nicely to the CENPA knockdown efficiency (at the protein level) the cell growth parameters, such as cell viability and sphere volume (TVSPW) showed moderate correlation.
Discussion
Uncontrolled cell division is a hallmark of all cancers, including glioblastoma. Consequently, several therapeutics that specifically target mitosis have been designed and tested in clinical settings (Dominguez-Brauer et al., 2015; Rath and Kozielski, 2012; De Witt Hamer et al., 2011; Herman et al., 2015; Kaneta and Ullrich, 2013; Lim et al., 2014; Sarcar et al., 2011; Chung et al., 2012) . CENPA is a centromere-associated variant of histone H3 that plays an important role during cell division by ensuring proper separation of the sister chromatids. It is frequently up-regulated in cancers (Zhang et al., 2014; Habel et al., 2013; Toh et al., 2011; Rajput et al., 2011; Hu et al., 2010; Biermann et al., 2007a; Biermann et al., 2007b; Furukawa et al., 2006; Li et al., 2007; Tomonaga et al., 2003; Qiu et al., 2013) and has been suggested as a potential therapeutic target Li et al., 2011) . A study in hepatocellular carcinoma revealed that CENPA was highly up-regulated at mRNA and protein levels in this cancer (Li et al., 2007; Li et al., 2011) . Knockdown of CENPA significantly decreased proliferation of hepatocellular carcinoma cell lines and reduced tumorigenic features in vivo (Li et al., 2011) .
We have recently identified a CENPA containing co-expression module highly up-regulated in glioblastoma tissue samples and GICs . Among the nine genes, CENPA was the most up-regulated one . Genes that show similar expression patterns might be functionally related. It was therefore not so surprising that these genes encoded proteins that were all part of the same functional network .
Association of CENPA with stemness and highly proliferative state was also observed in normal mammal cells (McGregor et al., 2014; Ambartsumyan et al., 2010) . In cardiac progenitors CENPA is not only highly up-regulated but its expression is also increased in the embryonic heart and down-regulated in the adult heart and upon differentiation (McGregor et al., 2014) . Knockdown of CENPA in cardiac progenitors slowed down cell proliferation (McGregor et al., 2014) . Our current study in GICs was in agreement with these results. We performed several tests to determine influence of CENPA knockdown on stemness of GICs. The number of spheres retrospectively indicates the number of GICs in the culture. Our study shows that the knockdown of CENPA gene severely impaired sphere formation by decreasing all three major parameters: number, diameter and volume of the spheres. However, only the number of spheres would suggest reduction in the population of GICs. The diameter and especially total volume of the spheres (TVSPW) are more related to cell growth (cell biomass) and proliferative capability as we previously reported Joel et al., 2015; Mughal et al., 2015) . In the present study we show that CENPA knockdown not only reduced the stemness of the GICs but also the cell viability, although the effect was rather mild. The results of the functional essays (SFA and cell viability) were further confirmed by assessing SOX2 and Ki67 expression. We detected a decrease in the expression of the stem cell marker SOX2 in CENPA knockdown cultures. The decrease in CENPA protein levels was also nicely paralleled by decrease in proliferation marker Ki67 levels. This was in agreement with another knockdown study where decrement in CENPA expression correlated with decreased Ki67 expression [56] . Although the complete loss of CENPA led to genomic instability and embryo lethality in mouse it has been shown that colorectal cancer cells can sustain some centromere function and assembly of kinetochore proteins even with as little as 1% of residual CENPA protein (Fachinetti et al., 2013) . Furthermore, the knockdown of CENPA in fibroblasts and iPS showed that the latter tolerated much better depletion of this gene (Ambartsumyan et al., 2010) . While fibroblasts featuring CENPA knockdown could not sustain functional centromeric mark the iPS could (Ambartsumyan et al., 2010) . The abovementioned examples from the literature could explain why the proliferation of our CENPA knockdown cultures was only mildly affected in spite of very good CENPA knockdown efficiency and reduction in Ki67 levels. In conclusion, our study shows that CENPA regulates stemness of GICs while the effect of this gene on cell proliferation is less evident.
Although CENPA protein is typically affiliated with centromeres its presence at active promoters has also been reported (Cole et al., 2011) . Frequently, this CENPA is quickly targeted for degradation (Hewawasam et al., 2010; Ranjitkar, 2010) . Abnormally increased CENPA expression, that is very often detected in human cancers, typically results in centromere expansion (Tomonaga et al., 2003) . In some cases CENPA nucleosomes can be detected in non-centromeric regions where the protein might lead to changes in gene regulation and chromosome fragility (Lam et al., 2006) . Furthermore it has been shown that CENPA can be recruited by artificially induced DNA brakes in osteosarcoma studies (Zeitlin et al., 2009 ). This phenomenon seems to be mediated by uracil DNA N-glycosylase (Zeitlin et al., 2011) . Some, so called, CENPA hotspots accumulate in chromosome telomeric regions such as region 8q24/Myc which is associated with genome instability (Athwal et al., 2015) . This particular region has been shown to influence glioma risk (Enciso-Mora et al., 2013) . Our study showed that CENPA was especially highly up-regulated in proneural GBM samples. Each of the four GBM subtypes is defined with a specific set of expressed genes, genetic aberrations and epigenetic marks (Verhaak et al., 2010) . It remains to be revealed why this particular subtype is associated with highest CENPA expression and if the eventual CENPA hotspot would be involved in this.
A comprehensive bioinformatic analysis of CENPs as a group has never been done. Neither has the role of CENPs in regulation of stemness been determined. In our study we included a large set of stem, progenitor and differentiated cells (Fig. 1) . Although, we focused especially on GICs this analysis revealed interesting information of CENPs' specific expression in differentiated cells and some tissues that we otherwise included only as controls (Fig. 1) . For example CENPI and CENPH were relatively lowly expressed while none of the CENPs was universally expressed in all tested cell cultures. CENPC1 and CENPV were specifically expressed in mature normal lymphocytes (Fig. 1A) and dopaminergic neurons (DNs), respectively. The latter was expressed both in DNs fully and those partially differentiated from iPS and in a few GIC cultures. CENPF was highly up-regulated only in partially differentiated DNs and otherwise in stem and progenitor cells, GBM, GICs and other breast cancer cells. All other CENPs were predominantly up-regulated in undifferentiated and partially differentiated cells and down-regulated in differentiated cells. Further refinement revealed that among the undifferentiated cells normal NSCs had slightly different profiles than the cancer cells and ESCs (Fig. 1B) . The analysis of the entire CENP profile in a number of cell types also revealed that undifferentiated and differentiated cells have quite distinct CENP profiles (Fig. 1A) .
Within the CCAN all CENPs can be divided in five groups (McKinley and Cheeseman, 2016): 1) CENP(C), 2) CENP(LN), 3) CENP(HIKM), 4) CENP(OPQUR) and 5) CENP(TWSX). The expression patterns of selected CENPs in undifferentiated cells (Fig. 1B) seem to be appropriately reflecting these functional groups. Out of 10 CENPs present on the bead chip (U/R/T/W/S and W were absent) nine were grouped as in CCAN (underlined). Firstly, CENPC showed an expression pattern quite different from the rest of the CENPs and formed its own group (Fig. 1A) . Secondly, L and N are in the same cluster while K, M and I clustered together. H clustered with L and N and was thus the only CENP outlier in this analysis. For all other CENPs the expression patterns at the mRNA level (hierarchical cluster analysis) reflected functionality in the CCAN complex.
CENPs do not seem to be randomly expressed in subtypes of GBM tissues in TCGA (Fig. 2D ). Proneural and neural groups exhibited CENP profiles quite distinct from the rest of tissues that belonged to classical and mesenchymal subgroups or were "unsorted" (black spheres in Fig.  2D ). Furthermore the two CENP signatures that we identified (Fig. 2F -G) correlated with very different patient survival (Fig. 2H) . Worse survival correlated with highly expressed CENPs: A, E, F, N and M. Best survival was obtained if these five CENPs were down-regulated (although CENPs B, C, T and Q were up-regulated). Genes with similar expression patterns might be functionally related. In predominantly undifferentiated cells CENPA was co-expressed with CENPB, CENPN, CNEPL and CENPH (Fig. 1B) . CENPN and CENPB are clearly very closely functionally related with CENPA as they are both inner kinetochore proteins (with CENPC) and directly recruited by CENPA (Guse et al., 2011; Carroll et al., 2009; Ando et al., 2002) . We previously showed that CENPF was highly up-regulated in GICs . Both in GICs and in GBM tissues CENPA, CENPE and CENPF were the part of the same network Stangeland et al., 2015) . A recent study showed that targeted disruption of PTEN leads to neoplastic transformation of human NSCs (Duan et al., 2015) . The reprogramming of NSCs towards a glioblastoma stem cell-like phenotype by PTEN KD leads also to up-regulation of CENPA, CENPE and CENPF (Duan et al., 2015) . In the current communication we show that several CENPs including these three genes (Fig. 1A) show similar expression patterns. Both CENPF and CENPE are required for the proper function of the kinetochore (Feng et al., 2006; Schaar et al., 1997; Yen et al., 1992) . CENPF is also implicated in other cancers such as esophageal squamous cell carcinoma (Pimkhaokham et al., 2000) . Is has been suggested as a therapeutic target and has been extensively targeted with a specific inhibitor GSK923295 (Wood et al., 2010) . Inhibition of CENPE induced tumor cell apoptosis and tumor regression and caused aneuploidy (Bennett et al., 2015) . Our bioinformatics analysis also showed that knockdowns of CENPA and CENPF resulted in similar downstream effects (Fig. 1D ). Taking into account that roles of CENPA, CENPE and CENPF in GICs are so intertwined, targeting all three simultaneously could be an interesting strategy. Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.nepig.2016.08.002.
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